CAS 1611493-60-7 | Bictegravir

Introduction
Bictegravir (BIC), a second-generation integrase strand transfer inhibitor (INSTI), has been approved for fixed-dose combination therapy with emtricitabine and tenofovir alafenami Chemicalbookde for HIV treatment against wild-type virus and A generation of drug-resistant strains has potent antiviral activity INSTIs in vitro.

Specification of CAS 1611493-60-7 | Bictegravir

Synthesis of CAS 1611493-60-7 | Bictegravir

Conditions

With lithium bromide In tetrahydrofuran at 60℃; Flow reactor;

Hot Tags: cas 1611493-60-7 | bictegravir, price, quotation, discount, in stock, for sale, Life Science